Henri Currie,
founder-in-residence

Henri is an aspiring biotech founder who is passionate about improving equitable access to life-transforming medicines for underrepresented populations. She is especially curious about autoimmune disease, women’s health, and gene regulation. Henri was previously a management consultant at McKinsey & Company, serving healthcare and life sciences organisations across Australia, the USA, and Japan. She completed her Bachelor of Biomedicine (Immunology, Bioinformatics) at the University of Melbourne and is thrilled to be back!